FTC sues major pharmacy benefit managers over insulin prices
The agency’s complaint filed Friday alleges CVS’ Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx steered patients toward higher priced insulin to bring in larger rebates from pharmaceutical manufacturers.